Postoperative and Peristomal Pyoderma Gangrenosum : Subtypes of Pyoderma Gangrenosum
Copyright © 2023 Elsevier Inc. All rights reserved..
Postoperative pyoderma gangrenosum and peristomal pyoderma gangrenosum are 2 subtypes of pyoderma gangrenosum. The diagnosis is made as a clinicopathologic correlation when assessing a rapidly progressing ulcer with irregular and undermined borders following a surgical procedure, trauma, or the creation of a stoma. Familiarity with the associated risk factors and distinguishing features of these disorders can facilitate prompt recognition, proper diagnosis, and the initiation of treatment. Management usually involves the use of corticosteroids and steroid-sparing agents as immunomodulators to shift the inflammatory neutrophilic dermatoses to chronic noninflammatory wounds and eventual healing.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:42 |
|---|---|
| Enthalten in: |
Dermatologic clinics - 42(2024), 2 vom: 29. März, Seite 171-181 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kipers, Théodora [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 04.03.2024 Date Revised 04.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.det.2023.12.001 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369135792 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369135792 | ||
| 003 | DE-627 | ||
| 005 | 20240304232726.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240301s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.det.2023.12.001 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1316.xml |
| 035 | |a (DE-627)NLM369135792 | ||
| 035 | |a (NLM)38423679 | ||
| 035 | |a (PII)S0733-8635(23)00106-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kipers, Théodora |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Postoperative and Peristomal Pyoderma Gangrenosum |b Subtypes of Pyoderma Gangrenosum |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.03.2024 | ||
| 500 | |a Date Revised 04.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 Elsevier Inc. All rights reserved. | ||
| 520 | |a Postoperative pyoderma gangrenosum and peristomal pyoderma gangrenosum are 2 subtypes of pyoderma gangrenosum. The diagnosis is made as a clinicopathologic correlation when assessing a rapidly progressing ulcer with irregular and undermined borders following a surgical procedure, trauma, or the creation of a stoma. Familiarity with the associated risk factors and distinguishing features of these disorders can facilitate prompt recognition, proper diagnosis, and the initiation of treatment. Management usually involves the use of corticosteroids and steroid-sparing agents as immunomodulators to shift the inflammatory neutrophilic dermatoses to chronic noninflammatory wounds and eventual healing | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Neutrophil | |
| 650 | 4 | |a Neutrophilic dermatoses | |
| 650 | 4 | |a Peristomal pyoderma gangrenosum | |
| 650 | 4 | |a Postoperative pyoderma gangrenosum | |
| 650 | 4 | |a Postsurgical | |
| 650 | 4 | |a Pyoderma gangrenosum | |
| 650 | 4 | |a Surgical wounds | |
| 650 | 4 | |a Ulcer | |
| 650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
| 700 | 1 | |a Tolkachjov, Stanislav N |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Dermatologic clinics |d 1990 |g 42(2024), 2 vom: 29. März, Seite 171-181 |w (DE-627)NLM012906700 |x 1558-0520 |7 nnns |
| 773 | 1 | 8 | |g volume:42 |g year:2024 |g number:2 |g day:29 |g month:03 |g pages:171-181 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.det.2023.12.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 42 |j 2024 |e 2 |b 29 |c 03 |h 171-181 | ||